Advertisement

Topics

Positive Phase III results for ALKS 3831 in schizophrenia

08:05 EDT 30 Jun 2017 | thePharmaLetter

Positive preliminary top-line results from ENLIGHTEN-1, the first of two key Phase III studies in the…

Original Article: Positive Phase III results for ALKS 3831 in schizophrenia

NEXT ARTICLE

More From BioPortfolio on "Positive Phase III results for ALKS 3831 in schizophrenia"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...